A cell transportation solution that preserves live circulating tumor cells in patient blood samples.
2017-12-08 08:12來源：原版作者：Stefansson S
Circulating tumor cells (CTCs) are typically collected into CellSave fixative tubes, which kills the cells, but preserves their morphology. Currently, the clinical utility of CTCs is mostly limited to their enumeration. More detailed investigation of CTC biology can be performed on live cells, but obtaining live CTCs is technically challenging, requiring blood collection into biocompatible solutions and rapid isolation which limits transportation options. To overcome the instability of CTCs, we formulated a sugar based cell transportation solution (SBTS) that stabilizes cell viability at ambient temperature. In this study we examined the long term viability of human cancer cell lines, primary cells and CTCs in human blood samples in the SBTS for transportation purposes.
Four cell lines, 5 primary human cells and purified human PBMCs were tested to determine the viability of cells stored in the transportation solution at ambient temperature for up to 7 days. We then demonstrated viability of MCF-7 cells spiked into normal blood with SBTS and stored for up to 7 days. A pilot study was then run on blood samples from 3 patients with metastatic malignancies stored with or without SBTS for 6 days. CTCs were then purified by Ficoll separation/microfilter isolation and identified using CTC markers. Cell viability was assessed using trypan blue or CellTracker? live cell stain.
Our results suggest that primary/immortalized cell lines stored in SBTS remain ~90% viable for > 72 h. Further, MCF-7 cells spiked into whole blood remain viable when stored with SBTS for up to 7 days. Finally, live CTCs were isolated from cancer patient blood samples kept in SBTS at ambient temperature for 6 days. No CTCs were isolated from blood samples stored without SBTS.
In this proof of principle pilot study we show that viability of cell lines is preserved for days using SBTS. Further, this solution can be used to store patient derived blood samples for eventual isolation of viable CTCs after days of storage. Therefore, we suggest an effective and economical transportation of cancer patient blood samples containing live CTCs can be achieved.
(BMC Cancer. 2016 May 6;16:300. )
- > 《醫學拾萃》2019年11月刊：靜脈血和末梢血在臨床檢測項目中的差別應用（續）
- > 《醫學拾萃》2019年10月刊：靜脈血和末梢血在臨床檢測項目中的差別應用
- > 《醫學拾萃》2019年9月刊：腎素-血管緊張素-醛固酮系統（RAAS）及其在相關疾病中的調節作用
- > 《醫學拾萃》2019年8月刊：樣本收集和液體活檢對胰腺癌早期診斷的意義
- > 《醫學拾萃》2019年7月刊：全血 RNA 管的應用以及基因表達譜
- > 《醫學拾萃》2019年6月刊：血小板釋放
- > 《醫學拾萃》2019年5月刊：臨檢樣本溶血的原因、鑒定以及對臨檢指標的影響
- > 《醫學拾萃》2019年4月刊：對臨檢樣本分析前誤差的來源和分布的統計
- > 《醫學拾萃》2019年3月刊：巨噬細胞與腫瘤細胞的多重互動及其臨床意義
- > 《醫學拾萃》2019年2月刊：中性粒細胞對腫瘤和循環腫瘤細胞的保護和促進作用